hexamethylene bisacetamide has been researched along with prostratin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aweya, JJ; Chen, D; Chen, M; Chen, R; Chen, X; Chen, Y; Liu, M; Lu, J; Wang, H; Wu, X | 1 |
Barat, C; Dental, C; Ouellet, M; Proust, A; Tremblay, MJ | 1 |
2 other study(ies) available for hexamethylene bisacetamide and prostratin
Article | Year |
---|---|
HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20/TNFAIP3 in NF-κB Signaling.
Topics: Acetamides; Drug Synergism; Feedback, Physiological; Gene Expression Regulation; HEK293 Cells; HeLa Cells; HIV Infections; HIV-1; Humans; I-kappa B Proteins; NF-kappa B; Phorbol Esters; Phosphorylation; Positive Transcriptional Elongation Factor B; Proviruses; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor alpha-Induced Protein 3 | 2016 |
HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.
Topics: Acetamides; Azacitidine; Azepines; Blood-Brain Barrier; Bryostatins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CCL2; Cytokines; Decitabine; HIV-1; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Phorbol Esters; Quinazolines; Receptors, Cell Surface; Virus Latency | 2017 |